7. •Levy’s.
Group I. First symptomatic attack.
A: Self limiting.
B: Require treatment.
Group II. Non treated patients with recurrences.
A: Asymptomatic, recurrent identified.
B: Recurrences in more of 3 months.
C: Recurrences in less then 3 months.
Page 7
8. •Levy’s.
Group III. Patients with recurrences despite treatment.
A: Detected by ECG
B: Recurrences after 3 months.
C: Recurrences before 3 months.
Page 8
11. A. Unique atrial contraction
focus close to pulmonary veins
generate reentrant waves.
B. Reentrant waves originated
in several ectopic focus in both
atriums.
Page 11
12. “X” indicate the origin of the impulse. Vertical lines AV conduction. Diagonal lines AV node
conduction and conduction around the reentrant circuit and perpendicular lines indicate
blockade. AJR: Accelerate Junction Rhythm.; MAT: Multifocal atrial tachycardia.; PAT:
Paroxistic Atrial Tachycardia.; RJT: Reentrant Junction tachycardia.; TACH, tachycardia.
Page 12
25. Acronym, year
Region
Europe,
Petro, 2007
North
Drugs tested
Doses of new
anticoagulant (mg)
Other antiplatelet
drugs and doses (mg)
Dabigatran vs
warfarin
50, 150, 300; all twice No aspirin, or 81 or
daily
325 mg
Dabigatran vs
warfarin
110 mg twice
Dabigatran vs
warfarin
150 mg twice
Edoxaban vs
30, 60, 120
America
Worldwide
Re-LY LD, 2009
Worldwide
Re-LY HW, 2009
Weitz, 2010
Worldwide
warfarin
daily
Daily
Concomitant use of
aspirin (at a dose of
<100 mg per day) or
other antiplatelet
agents was permitted
Concomitant use of
aspirin (at a dose of
<100 mg per day) or
other antiplatelet
agents was permitted
No restriction about
aspirin
Page 25
26. Acronym, year
ARISTOTLE J, 2011
Region
Asia
Drugs tested
Apixaban vs warfarin
Doses of new
Other antiaplatelet
anticoagulant (mg)
drugs and doses (mg)
2.5; 5; all twice daily
No restriction about
aspirin
No restriction about
aspirin lower than 165
ARISTOTLE, 2011
Worldwide
Apixaban vs warfarin
5 twice daily
mg. Aspirin and
clopidogrel together
use were exclusion
criteria
Aspirin ≤100 mg
Rocket AF, 2011
Worldwide
Rivaroxaban vs
warfarin
20
monotherapy and
thienopyridine
monotherapy allowed.
Edoxaban vs
Chung, 2011
Asia
No restriction about
30, 60
warfarin
aspirin
Page 26
38. 1. Wagner, Galen S. Marriot’s Practical Electrphysiology. 11th edition
2. Sociedad Española de Cardiología. Primer curso de electrocardiografía de la SEC. 2010.
3. Arango, Ramirez y Durango. Electrocardiografía y Arritmias. Sociedad Colombiana de
Cardiología. 2010.
4. Charría y col. Texto de Cardiología. Sociedad Colombiana de Cardiología. 2007.
5. Branwald’s Heart Disease. 9na edición. Editorial ELSAVIER. 2011.
6. Heist y col. Rate control in Atrial Fibrillation: targets, methods, resynchronization considerations.
Circulation 2011, 124: 2746-2755.
7. 2011 ACCF/AHA/HRS Focused update on the magnament of patients with Atrial fibrillation
(updating 2006 guidelines): a report of the American College of Cardiology
Foundation/American Heart Association Task force on practice guidelines.
8. Camm y col. Guidelines for the magnaments of atrial fibrillation. European Heart Journal 2010.
31, 2369-2429.
9. Zipes. Cardial Electrophysiology. From cell to bedside. 5th edition. Saunders editorial.
10. Heidbuchel et al. EHRA Practical guidelines on use of NOACs in patients with non-valvular AF
(2013) Europace 15, 625-651.
Page 38